Moleculin Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Moleculin Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2015 to Q4 2024.
  • Moleculin Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$1.88M, a 81.7% increase year-over-year.
  • Moleculin Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$21.8M, a 26.9% increase year-over-year.
  • Moleculin Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$21.8M, a 26.9% increase from 2023.
  • Moleculin Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.8M, a 2.56% decline from 2022.
  • Moleculin Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29M, a 82.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$21.8M -$1.88M +$8.39M +81.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-21
Q3 2024 -$30.2M -$10.6M -$4.98M -88.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$25.2M -$4.32M +$1.66M +27.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-08
Q1 2024 -$26.8M -$4.97M +$2.95M +37.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-08
Q4 2023 -$29.8M -$10.3M -$3.5M -51.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-21
Q3 2023 -$26.3M -$5.61M +$3M +34.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$29.3M -$5.98M +$801K +11.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-08
Q1 2023 -$30.1M -$7.92M -$1.05M -15.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-08
Q4 2022 -$29M -$6.77M -$3.94M -140% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$25.1M -$8.61M -$4.23M -96.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$20.8M -$6.78M -$2.53M -59.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$18.3M -$6.87M -$2.42M -54.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$15.9M -$2.83M -$187K -7.09% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$15.7M -$4.38M -$984K -29% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$14.7M -$4.24M +$5.87M +58% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$20.6M -$4.45M -$3.24M -268% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$17.4M -$2.64M +$1.16M +30.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$18.5M -$3.4M +$750K +18.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$19.3M -$10.1M -$8.89M -728% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$10.4M -$1.21M +$2.83M +70.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$13.2M -$3.8M -$1.01M -36.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$12.2M -$4.15M -$2.11M -103% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$10.1M -$1.22M +$3.9M +76.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$14M -$4.04M -$2.11M -110% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$11.9M -$2.79M +$400K +12.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$12.3M -$2.04M +$828K +28.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$13.1M -$5.13M -$1.7M -49.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$11.4M -$1.93M -$1.6M -486% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$9.81M -$3.19M -$1.76M -124% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 -$8.04M -$2.87M -$1.43M -100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$6.61M -$3.42M -$2.69M -363% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$3.92M -$329K +$3K +0.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$3.93M -$1.42M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 -$1.43M -$1.21M -538% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$739K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$332K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2015 -$224K Jul 28, 2015 Sep 30, 2015 10-Q 2016-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.